Among the 10 NSCLC patients whose tumors were positive for the EML4-ALK gene rearrangements, 1 patient had a partial remission (PR), 2 patients achieved unconfirmed PR, and 4 patients had stable disease (Kwak et al., 2009). The gene discussed is ALK; the disease is non-small cell lung carcinoma.